Dr. Zhui Chen

Biography

      "Dr. Zhui Chen is a seasoned biologist and drug hunter with more than 10 years of drug discovery and development experience in top biopharmaceutical companies. He has participated in multiple programs from early discovery to translational research and clinical development, including the FDA-approved Bcl-2 inhibitor Venetoclax (ABT-199).   Before co-founding Abbisko, Dr. Chen served as the Head of liver cancer discovery and translational research and later lung cancer discovery at Johnson & Johnson China R&D. Prior to that, he was an Investigator of epigenetic drug discovery and leader of oncology translational research at Novartis China and Senior Scientist at Abbott Lab, USA.  Dr. Chen started his undergraduate study at Peking University and obtained B.S. degree from the University of Texas at Austin. He obtained his Ph.D. in Biochemistry from Duke University and then conducted his postdoctoral research at the University Of Texas Southwestern Medical Center. "  

Research Interest

cancer discovery